Updated July 2026 · 9 min read

Aminoglycosides for ICU Nurses 2026 — Powerful, Cheap, and Unforgiving

Part of the ICU Emergencies Hub — browse every related guide in one place.

Gentamicin, tobramycin, and amikacin are among the oldest antibiotics still in daily ICU use — fast, bactericidal against tough gram-negative organisms, and inexpensive. They are also narrow-margin drugs: the same concentration that kills Pseudomonas can injure kidneys and permanently damage hearing and balance. For the bedside nurse, aminoglycosides are a lesson in why we draw levels.

What they cover and how they kill

Aminoglycosides bind the bacterial 30S ribosome and shut down protein synthesis, killing in a concentration-dependent way: the higher the peak relative to the organism's MIC, the more bacteria die. They also produce a useful post-antibiotic effect, continuing to suppress growth even after the drug level falls — the pharmacologic basis for giving a big dose once a day instead of small doses around the clock.

Their coverage is aimed at aerobic gram-negative rods, including Pseudomonas aeruginosa, and they are frequently added to a beta-lactam for synergy in serious infections such as gram-negative bacteremia or enterococcal endocarditis. What they do not do is just as important: they have essentially no activity against anaerobes, and because their uptake into bacteria requires oxygen, they perform poorly in abscesses and acidic, poorly perfused tissue. That is why they are almost always a partner drug, not a solo agent.

Extended-interval vs traditional dosing

Two dosing strategies coexist, and knowing which one your patient is on changes how you interpret levels.

Extended-interval (once-daily) dosing gives a large weight-based dose at a long interval (commonly every 24 hours, lengthened in renal impairment). It exploits concentration-dependent killing and the post-antibiotic effect, and by allowing the level to fall to near-zero between doses it gives the kidney tubules a daily rest — which reduces toxicity. Monitoring often uses a single random level plotted on a nomogram, or a trough, rather than a classic peak-and-trough pair.

Traditional (multiple-daily) dosing gives smaller doses every 8–12 hours and is still used in specific situations — pregnancy, significant burns, ascites, endocarditis synergy, and some pediatric cases — where extended-interval pharmacokinetics don't apply cleanly. Here you monitor a peak (drawn about 30 minutes after the infusion ends, to confirm the dose is high enough to work) and a trough (drawn just before the next dose, to confirm the drug has cleared enough to be safe).

Nephrotoxicity: usually reversible, always watched

Aminoglycosides accumulate in the proximal renal tubule and can cause a non-oliguric acute kidney injury, typically appearing several days into therapy as a slow creatinine rise. The good news is it is usually reversible once the drug stops; the risk rises with longer courses, higher troughs, volume depletion, older age, and co-administration of other nephrotoxins — vancomycin, contrast dye, NSAIDs, loop diuretics, amphotericin. At the bedside, watch the daily creatinine and urine output trend, keep the patient volume-replete, and flag stacking nephrotoxins to the team.

Ototoxicity: the harm that doesn't come back

Risk climbs with prolonged therapy, high cumulative dose, elevated troughs, and concurrent loop diuretics. Some patients carry a mitochondrial genetic variant that makes them exquisitely susceptible, so a family history of aminoglycoside-related deafness is worth surfacing.

Neuromuscular blockade: the anesthesia-adjacent trap

Aminoglycosides can potentiate neuromuscular blockade by interfering with acetylcholine release at the junction. In most patients this is negligible, but it becomes clinically real in the patient who also received a paralytic, has myasthenia gravis, or has profound hypomagnesemia/hypocalcemia. The practical consequence: watch for prolonged weakness or delayed extubation after surgery in a patient dosed with an aminoglycoside, and know that intravenous calcium is the reported reversal.

Bedside summary

Related: Vancomycin guide · Cefepime guide · Piperacillin-tazobactam (Zosyn) guide · Meropenem guide

Educational content for licensed clinicians. Always follow your facility's pharmacy dosing protocol and provider orders. Not medical advice.